2022 WGND Annual Meeting
The Stop TB Partnership Working Group on New Drugs (WGND)’ Annual Meeting will take place virtually on 3 November 2022.
During the meeting, updates will be provided by representatives from pharmaceutical, government agencies, research organizations, non-profits, academia, and others involved in TB research and development. The meeting will provide an overview of the current state of the Global TB Drug Pipeline with representatives providing updates on active trials, collaborations, novel compounds, and treatment research.
Representatives from the following groups will be presenting updates:
- Gates Medical Research Institute
- UNITE4TB
- AIDS Clinical Trials Group
- US CDC TB Trials Consortium
- TRUNCATE-TB Clinical Trial
- endTB / endTB-Q Clinical Trials
- TB Alliance
- Otsuka Pharmaceuticals
- Janssen
- GlaxoSmithKline
- SMART4TB
- PanACEA & LMU Munich
The meeting will be held using Zoom Webinar. To join the virtual meeting, click here to register.
Source:
WGND
